05/07/2024 4:31 PM | Jazz Pharmaceuticals (Issuer) Patil Neena M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 6:38 AM | Jazz Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/09/2024 3:39 PM | GALA RENEE D (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 5:07 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 8:49 PM | Jazz Pharmaceuticals (Issuer) Pearce Samantha (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 8:53 PM | GALA RENEE D (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 8:44 PM | COZADD BRUCE C (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/07/2024 8:47 PM | Iannone Robert (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 8:48 PM | Jazz Pharmaceuticals (Issuer) Patil Neena M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 5:09 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 6:54 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:58 PM | Henderson Mary Elizabeth (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:28 PM | Jazz Pharmaceuticals (Issuer) Johnson Philip L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:32 PM | Jazz Pharmaceuticals (Issuer) Kennedy Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:34 PM | COZADD BRUCE C (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:44 PM | GALA RENEE D (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:47 PM | Iannone Robert (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:50 PM | Jazz Pharmaceuticals (Issuer) Patil Neena M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:52 PM | Jazz Pharmaceuticals (Issuer) Pearce Samantha (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:11 PM | Jazz Pharmaceuticals (Issuer) Kennedy Patrick (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/05/2024 6:14 PM | Jazz Pharmaceuticals (Issuer) Johnson Philip L (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/01/2024 2:11 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024 3:06 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/27/2024 6:45 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/21/2024 6:46 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 6:29 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
01/25/2024 4:01 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/24/2024 8:46 AM | BlackRock Inc. (Filed by) Jazz Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/19/2024 5:19 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 5:21 PM | COZADD BRUCE C (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 5:23 PM | GALA RENEE D (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 5:25 PM | Iannone Robert (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 5:28 PM | Jazz Pharmaceuticals (Issuer) Patil Neena M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 5:33 PM | Jazz Pharmaceuticals (Issuer) Pearce Samantha (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 6:45 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/15/2023 6:45 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/06/2023 3:39 PM | Jazz Pharmaceuticals (Issuer) Smith Mark Douglas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 3:31 PM | Cook Jennifer E. (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2023 6:36 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2023 12:33 PM | Jazz Pharmaceuticals (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
09/06/2023 4:09 PM | Jazz Pharmaceuticals (Issuer) Patil Neena M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Trump’s “Tax Free” Retirement Strategy (Ad) Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value.
In other words, a dollar back then would buy $17.82 worth of goods in today's money.
If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… |
09/01/2023 3:39 PM | Jazz Pharmaceuticals (Subject) Patil Neena M (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/31/2023 5:44 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2023 4:41 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/17/2023 4:21 PM | Jazz Pharmaceuticals (Issuer) Patil Neena M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 6:49 PM | Jazz Pharmaceuticals (Issuer) O'Keefe Kenneth W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 6:51 PM | Jazz Pharmaceuticals (Issuer) ORiordan Anne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 4:58 PM | Jazz Pharmaceuticals (Issuer) RIEDEL NORBERT G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 5:00 PM | Jazz Pharmaceuticals (Issuer) Smith Mark Douglas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 5:02 PM | Jazz Pharmaceuticals (Issuer) Sohn Catherine A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 5:08 PM | Jazz Pharmaceuticals (Issuer) Winningham Rick E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 4:47 PM | Gray Peter (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 4:49 PM | Henderson Mary Elizabeth (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 4:52 PM | Jazz Pharmaceuticals (Issuer) McSharry Heather Ann (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 4:56 PM | Jazz Pharmaceuticals (Issuer) Mulligan Seamus (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 4:40 PM | Jazz Pharmaceuticals (Subject) Patil Neena M (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023 4:43 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 4:44 PM | Cook Jennifer E. (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 4:45 PM | ENRIGHT PATRICK G (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 8:55 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 8:35 PM | Jazz Pharmaceuticals (Subject) Winningham Rick E (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 8:40 PM | Gray Peter (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 8:28 PM | ENRIGHT PATRICK G (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 8:00 PM | Jazz Pharmaceuticals (Subject) McSharry Heather Ann (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 8:04 PM | Cook Jennifer E. (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 8:09 PM | Jazz Pharmaceuticals (Subject) O'Keefe Kenneth W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 8:15 PM | Jazz Pharmaceuticals (Subject) Smith Mark Douglas (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 8:19 PM | Jazz Pharmaceuticals (Subject) RIEDEL NORBERT G (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 7:54 PM | Jazz Pharmaceuticals (Subject) Sohn Catherine A. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 7:36 PM | Jazz Pharmaceuticals (Subject) ORiordan Anne (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 5:41 PM | Henderson Mary Elizabeth (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
06/22/2023 3:05 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/16/2023 3:12 PM | Jazz Pharmaceuticals (Filer)
| Form DEF 14A | |
06/12/2023 3:47 PM | Jazz Pharmaceuticals (Issuer) Mulligan Seamus (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 6:12 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023 6:15 PM | Jazz Pharmaceuticals (Issuer) Sablich Kim (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 6:16 PM | Iannone Robert (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 7:24 PM | Jazz Pharmaceuticals (Issuer) Patil Neena M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/01/2023 5:01 PM | Jazz Pharmaceuticals (Subject) Patil Neena M (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/19/2023 7:45 PM | GALA RENEE D (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/18/2023 6:38 PM | GALA RENEE D (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/10/2023 3:08 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |